Traditional Chinese medical therapy for functional dyspepsia based on differentiation between cold and heat, and asthenia and sthenia

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-10001074

Enrollment

Unknown

Registered

2010-11-08

Start date

2009-03-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

functional dyspepsia

Interventions

A:Weibing I, spleen-stomach deficiency-cold syndrome

B:Weibing II, spleen deficiency and qi stagnation sy

C:Weibing III, spleen-stomach dampness-heat syndrome

D:Weibing IV, spleen-stomach dampness-heat syndrome

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients who meet the Rome III diagnosis standard of functional dyspepsia; 2. Patients who have the spleen-stomach deficiency-cold syndrome, spleen deficiency and qi stagnation syndrome, spleen-stomach dampness-heat syndrome or cold-heat intertwist syndrome; 3. Patients aged 18 to 65 without gender limitation; 4. Singed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients who combined with GI ulcer, erosive gastritis, atrophic gastritis, severe dysplasia of gastric mucosa or suspicious malignant lesion; 2. Patients who have overlap syndrome combined with gastroesophageal reflux disease or irritable bowel syndrome; 3. Patients whose syndrome is difficult to differentiate; 4. Patients who have connective tissue diseases, diabetes or other endocrine disease, climacteric syndrome, or severe diseases in heart, liver, lung, kidney, blood; 5. Pregnant or lactating women. Disabled people; 6. Patients with history of alcoholic or drug abuse; 7. Patients who have allergic constitution or known to be allergic to the drug used in this trial; 8. Patients who are involved in other trials; 9. Patients with poor compliance or other reasons that the researcher considered not to be appropriate to participate in this trial; 10. patients with severe depression and have suicidal tendency.

Design outcomes

Primary

Measure	Time frame
Modified Tack scale for symptoms of dyspepsia;traditional Chinese medical syndromes;Modified Nepean Dyspepsia Index for single symptom;	—

Secondary

Measure	Time frame
Quality of Life;Hamilton Anxiety Scale (HAMA) and Hamilton Depress;Indices of visceral sensitivity test;Gastrointestinal dynamic index;	—

Countries

China

Contacts

Public ContactShengsheng Zhang

zss2000@sohu.com+86 10 52176634

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 24, 2026